Back to Top
Focusing on how new innovative AI and ML technologies are being used currently by healthcare organisations, and how they will next provide a pathway to powerful and disruptive new innovation capabilities.
Sensyne applies AI algorithms to anonymised data to find potential clinical solutions which can be later sold to pharmaceutical companies.
Researchers have claimed the system is able to identify 10 features of eye diseases from optical coherence tomography (OCT) scans.
Researchers have suggested that ‘poor quality’ data held by NHS Digital could limit the effectiveness of new technologies and health policies.
The UK government is investing £37.5 million in hubs connecting regional health and care data with genetic and biomedical information.
Harpreet Sood from NHS England said the documents will help provide ‘principles’, ‘guidance’ and ‘transparency’ for the use of AI within the NHS.
British healthtech start-up Medopad has announced that it is expanding across the Atlantic following a whirlwind success story in the UK.
